Director's Messages

Joni Rutter kicks off a new message series on progress and priorities in rare diseases research across the translational pipeline.

Joni Rutter gives an overview of the NCATS Strategic Plan for 2025–2030 and shares next steps.

Joni Rutter shares how the CTSA Program is addressing big barriers to clinical trials.

Joni Rutter describes the translational science principles that enable impactful data innovations.

Joni Rutter describes the approaches NCATS used to build more accurate models for drug discovery and development.

Joni Rutter defines key terms, describes some of the bottlenecks and introduces the principles enabling our work.

Joni Rutter shares her goals for NCATS’ next strategic plan and ways the translational science community can build it together.

Joni Rutter reflects on NCATS’ COVID-19 activities and the insights we gained that can ready us for the future.

Joni Rutter reflects on her selection as NCATS director, the Center’s culture and her bold goals for the future.

Joni Rutter discusses the important role of our stakeholders in bringing more treatments to all people more quickly.